Positron emission tomography: from production and distribution to drug research and clinical applications.

R. E. Coleman; E. M. Bednarczyk; H. Chilton

doi:10.1016/s1086-5802(16)31201-3

Positron emission tomography: from production and distribution to drug research and clinical applications.

R. E. Coleman
, E. M. Bednarczyk
, H. Chilton

Pharmacy

Duke University

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The radiopharmaceutical FDG has had a major impact on PET imaging in clinical medicine, particularly in the detection and staging of certain cancers. PET isotopes offer unparalleled insight into in vivo distribution of labeled drugs. PET imaging of blood flow, metabolism, and neuroreceptor characteristics may provide new perspectives on the mechanism of action and effects of drugs.

Original language	English
Pages (from-to)	S66-67
Journal	Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Volume	40
Issue number	5 Suppl 1
DOIs	https://doi.org/10.1016/s1086-5802(16)31201-3
State	Published - 2000

Access to Document

10.1016/s1086-5802(16)31201-3

Cite this

@article{2ff20d954c7f4ac98f728d52195c573a,

title = "Positron emission tomography: from production and distribution to drug research and clinical applications.",

abstract = "The radiopharmaceutical FDG has had a major impact on PET imaging in clinical medicine, particularly in the detection and staging of certain cancers. PET isotopes offer unparalleled insight into in vivo distribution of labeled drugs. PET imaging of blood flow, metabolism, and neuroreceptor characteristics may provide new perspectives on the mechanism of action and effects of drugs.",

author = "Coleman, \{R. E.\} and Bednarczyk, \{E. M.\} and H. Chilton",

year = "2000",

doi = "10.1016/s1086-5802(16)31201-3",

language = "English",

volume = "40",

pages = "S66--67",

journal = "Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)",

issn = "1086-5802",

publisher = "American Pharmaceutical Association",

number = "5 Suppl 1",

}

TY - JOUR

T1 - Positron emission tomography

T2 - from production and distribution to drug research and clinical applications.

AU - Coleman, R. E.

AU - Bednarczyk, E. M.

AU - Chilton, H.

PY - 2000

Y1 - 2000

N2 - The radiopharmaceutical FDG has had a major impact on PET imaging in clinical medicine, particularly in the detection and staging of certain cancers. PET isotopes offer unparalleled insight into in vivo distribution of labeled drugs. PET imaging of blood flow, metabolism, and neuroreceptor characteristics may provide new perspectives on the mechanism of action and effects of drugs.

AB - The radiopharmaceutical FDG has had a major impact on PET imaging in clinical medicine, particularly in the detection and staging of certain cancers. PET isotopes offer unparalleled insight into in vivo distribution of labeled drugs. PET imaging of blood flow, metabolism, and neuroreceptor characteristics may provide new perspectives on the mechanism of action and effects of drugs.

UR - https://www.scopus.com/pages/publications/17744404192

U2 - 10.1016/s1086-5802(16)31201-3

DO - 10.1016/s1086-5802(16)31201-3

M3 - Article

C2 - 11029876

AN - SCOPUS:17744404192

SN - 1086-5802

VL - 40

SP - S66-67

JO - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

JF - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

IS - 5 Suppl 1

ER -

Positron emission tomography: from production and distribution to drug research and clinical applications.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this